Declining and rebounding unhealthy alcohol consumption during the first year of HIV care in rural Uganda, using phosphatidylethanol to augment self-report

Aims We examined whether unhealthy alcohol consumption, which negatively impacts HIV outcomes, changes after HIV care entry overall and by several factors. We also compared using phosphatidylethanol (PEth, an alcohol biomarker) to augment self‐report to using self‐report alone. Design A prospective...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Addiction (Abingdon, England) England), 2016-02, Vol.111 (2), p.272-279
Hauptverfasser: Hahn, Judith A., Emenyonu, Nneka I., Fatch, Robin, Muyindike, Winnie R., Kekiibina, Allen, Carrico, Adam W., Woolf-King, Sarah, Shiboski, Stephen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aims We examined whether unhealthy alcohol consumption, which negatively impacts HIV outcomes, changes after HIV care entry overall and by several factors. We also compared using phosphatidylethanol (PEth, an alcohol biomarker) to augment self‐report to using self‐report alone. Design A prospective 1‐year observational cohort study with quarterly visits. Setting Large rural HIV clinic in Mbarara, Uganda. Participants A total of 208 adults (89 women and 119 men) entering HIV care, reporting any prior year alcohol consumption. Measurements Unhealthy drinking was PEth+ (≥ 50 ng/ml) or Alcohol Use Disorders Identification Test–Consumption+ (AUDIT‐C+, over 3 months, women ≥ 3; men ≥ 4). We calculated adjusted odds ratios (AOR) for unhealthy drinking per month since baseline, and interactions of month since baseline with perceived health, number of HIV symptoms, antiretroviral therapy (ART), gender and self‐reported prior unhealthy alcohol use. Findings The majority of participants (64%) were unhealthy drinkers (PEth+ or AUDIT‐C+) at baseline. There was no significant trend in unhealthy drinking overall [per‐month AOR: 1.01; 95% confidence interval (CI) = 0.94–1.07], while the per‐month AORs were 0.91 (95% CI = 0.83–1.00) and 1.11 (95% CI = 1.01–1.22) when participants were not yet on ART and on ART, respectively (interaction P‐value
ISSN:0965-2140
1360-0443
DOI:10.1111/add.13173